Concepedia

Jakob Loschko

JL

Statistics

Publications

23

Citations

4.9K

H-Index

21

Active since

2011

Affiliations

Pfizer (United States)(Current)

Rockefeller University

The University of Texas Medical Branch at Galveston

Johannes Gutenberg University Mainz

University Medical Center of the Johannes Gutenberg University Mainz

Jakob Loschko is an author at Pfizer (United States) specializing in immunology, life sciences, and immunization.

Publications per year

2011–2024

23

Publications

23

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text

, , +16

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Annette B. Vogel, Isis Kanevsky, Ye Che et al. · Nature · 2021 · 741 citations · Full text

, , +14

Classical dendritic cells are required for dietary antigen–mediated induction of peripheral Treg cells and tolerance

Daria Esterházy, Jakob Loschko, Mariya London et al. · Nature Immunology · 2016 · 305 citations

, , +16

The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells

Shinelle Menezes, Daisy Melandri, Giorgio Anselmi et al. · Immunity · 2016 · 287 citations · Full text

, , +17

Intestinal monocytes and macrophages are required for T cell polarization in response to <i>Citrobacter rodentium</i>

Heidi A. Schreiber, Jakob Loschko, Roos A. Karssemeijer et al. · The Journal of Experimental Medicine · 2013 · 193 citations · Full text

, , +17

1–5 of 23